Clinical Trial Update: Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating interferon alfa in patients who had received cancer vaccines. The study was terminated and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: Duke University | Conditions: Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-07-16